BROOKLYN IMMUNOTHERAPEUTICS, INC.

(BTX)
  Report
Delayed Nasdaq  -  05/20 04:00:01 pm EDT
0.7177 USD   -3.73%
04/21Brooklyn ImmunoTherapeutics Announces Establishment of New Research and Development Facility for Advancement of Engineered Cellular Medicines
AQ
04/21Brooklyn ImmunoTherapeutics, Inc. Announces Establishment of New Research and Development Facility for Advancement of Engineered Cellular Medicines
CI
04/19BROOKLYN IMMUNOTHERAPEUTICS, INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

BROOKLYN IMMUNOTHERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)

12/21/2021 | 04:35pm EDT

Item 5.02 Departure of Directors or Certain Officers; Election of Directors;

          Appointment of Certain Officers; Compensatory Arrangements of Certain
          Officers.


On December 16, 2021, Luba Greenwood notified the board of directors of her intention to resign as a director effective as of January 1, 2022. Ms. Greenwood's decision to resign was not the result of any disagreement with us on any matter relating to our operations, policies or practices.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

All news about BROOKLYN IMMUNOTHERAPEUTICS, INC.
04/21Brooklyn ImmunoTherapeutics Announces Establishment of New Research and Development Fac..
AQ
04/21Brooklyn ImmunoTherapeutics, Inc. Announces Establishment of New Research and Developme..
CI
04/19BROOKLYN IMMUNOTHERAPEUTICS, INC. : Changes in Registrant's Certifying Accountant, Financi..
AQ
04/18Brooklyn ImmunoTherapeutics Shares Slide After Company Reports Q4 Loss
MT
04/18Brooklyn ImmunoTherapeutics Announces Fourth Quarter and Full Year 2021 Financial Resul..
AQ
04/15BROOKLYN IMMUNOTHERAPEUTICS : Announces Fourth Quarter and Full Year 2021 Financial Result..
PU
04/15BROOKLYN IMMUNOTHERAPEUTICS, INC. : Results of Operations and Financial Condition, Regulat..
AQ
04/15Brooklyn ImmunoTherapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended..
CI
04/15BROOKLYN IMMUNOTHERAPEUTICS, INC. Management's Discussion and Analysis of Financial Co..
AQ
04/15Brooklyn ImmunoTherapeutics, Inc. Reports Earnings Results for the Full Year Ended Dece..
CI
More news
Analyst Recommendations on BROOKLYN IMMUNOTHERAPEUTICS, INC.
More recommendations